Finance leaders have a timely opportunity to enhance liquidity, reduce tax burdens and align tax policy with business growth.
Join the Future of Work & the Innovation Economy initiative to discuss the concern about indirect costs, the FAIR model, and the potential impact it would have on university R&D partnerships with ...
Under the Merged Scheme, the rules around claiming for subcontractor costs have been simplified to some extent, which is great for advisers and ...
The U.S. Capitol in Washington, DC. A bipartisan group of lawmakers has reintroduced legislation to allow immediate expensing of research and development costs, all the way back to 2022 when the tax ...
The new Section 174A that came out of the One Big Beautiful Bill Act establishes different rules for past and future research and development spending — creating an opportunity for advisors. For tax ...
One of the most lucrative tax breaks corporate America won in Donald Trump’s signature economic legislation is hitting a roadblock in a minimum tax Congress set three years ago under Joe Biden.
For accounting periods starting April 2024, only R&D activity carried out in the UK qualifies for relief under the new merged ...
Tustin-based Peregrine Pharmaceuticals Inc. said Friday that higher research and staffing costs led to a larger loss in the quarter ended Oct. 31. Peregrine, which is developing drugs to treat ...
As competition in the artificial intelligence industry intensifies, OpenAI has decided to invest $350 billion by 2030, focusing on computing power and research and development. This massive investment ...
Pharma R&D faces rising trial complexity, high costs, and patient and investigator shortages, driving the need for adaptive models and data-driven strategies to speed therapies to market.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results